Brief: Spectral Announces Approval Of Tigris Trial By The US FDA
19/02/2019 13:12
Feb 19 (Reuters) - Spectral Medical Inc EDT.TO :
* SPECTRAL ANNOUNCES APPROVAL OF TIGRIS TRIAL BY THE US FDA
Source text for Eikon: ID:nGNXbGsx33
Further company coverage: EDT.TO
(Reuters.Briefs@thomsonreuters.com)
Recent news on Spectral Medical
See all newsBrief: Spectral Medical Provides Update Following In-Person FDA 100-Day Meeting For PMX PMA
Canada's Spectral Medical Q2 revenue falls on lower reagent sales
Brief: Spectral Medical And Vantive Announce Topline 12 Month Follow-Up Results From Spectral’S Tigris Trial
Canada's Spectral Medical Q1 revenue rises 56%, net loss narrows
Spectral Medical Q3 revenue up 34%